Verona Pharma plc (I9SA) — Financial Flexibility Index
Verona Pharma plc (I9SA) has a Financial Flexibility Index of 0.10x as of June 2025. Free cash flow of €30.56 Million (operating CF €30.56 Million minus capex €0.00) represents 0% of total liabilities (€294.60 Million). Also explore how fast is Verona Pharma plc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Verona Pharma plc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Verona Pharma plc across 9 annual periods. Check Verona Pharma plc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Verona Pharma plc (2016–2024)
Year-by-year free cash flow to debt coverage for Verona Pharma plc. For the full company profile including market capitalisation, see Verona Pharma plc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.45x | €-121.62 Million | €-122.20 Million | €269.68 Million | ▲ +47.2% |
| 2023 | -0.85x | €-50.22 Million | €-50.22 Million | €58.84 Million | ▲ +58.6% |
| 2022 | -2.06x | €-59.83 Million | €-59.86 Million | €29.00 Million | ▼ -139.4% |
| 2021 | -0.86x | €-33.24 Million | €-33.25 Million | €38.58 Million | ▲ +62.9% |
| 2020 | -2.33x | €-44.99 Million | €-45.08 Million | €19.35 Million | ▲ +19.8% |
| 2019 | -2.90x | €-42.81 Million | €-42.87 Million | €14.78 Million | ▼ -130.1% |
| 2018 | -1.26x | €-18.10 Million | €-18.11 Million | €14.37 Million | ▲ +20.8% |
| 2017 | -1.59x | €-20.69 Million | €-20.70 Million | €13.00 Million | ▼ -322.1% |
| 2016 | -0.38x | €-5.43 Million | €-5.59 Million | €14.40 Million | — |